{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:16Z","timestamp":1789726216680,"version":"4.0.1"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Chronic Kidney Disease (CKD), a disorder that affects 11% of the world's population, is characterized by an acceleration in skeletal, immune, renal, and cardiovascular aging that increases the risk of cardiovascular mortality by 10- to 20-fold, compared to that in individuals with normal renal function. For more than two decades, the progressive impairment in renal capacity to maintain normal circulating levels of the hormonal form of vitamin D (1,25-dihydroxyvitamin D or calcitriol) was considered the main contributor to the reduced survival of CKD patients. Accordingly, calcitriol administration was the treatment of choice to attenuate the progression of secondary hyperparathyroidism (SHPT) and its adverse impact on bone health and vascular calcification. The development of calcitriol analogs, designed to mitigate the resistance to calcitriol suppression of PTH associated with CKD progression, demonstrated survival benefits unrelated to the control of SHPT or skeletal health. The exhaustive search for the pathophysiology behind survival benefits associated with active vitamin D analogs has identified novel anti-inflammatory, anti-hypertensive, anti-aging actions of the vitamin D endocrine system. A major paradigm shift regarding the use of calcitriol or active vitamin D analogs to improve survival in CKD patients emerged upon demonstration of a high prevalence of vitamin D (not calcitriol) deficiency at all stages of CKD and, more significantly, that maintaining serum levels of the calcitriol precursor, 25(OH)vitamin D, above 23 ng\/ml delayed CKD progression. The cause of vitamin D deficiency in CKD, however, is unclear since vitamin D bioactivation to 25(OH)D occurs mostly at the liver. Importantly, neither calcitriol nor its analogs can correct vitamin D deficiency. The goals of this chapter are to present our current understanding of the pathogenesis of vitamin D deficiency in CKD and of the causal link between defective vitamin D bioactivation to calcitriol and the onset of molecular pathways that promote CKD progression independently of the degree of SHPT. An understanding of these mechanisms will highlight the need for identification of novel sensitive biomarkers to assess the efficacy of interventions with vitamin D and\/or calcitriol(analogs) to ameliorate CKD progression in a PTH-independent manner.<\/jats:p>","DOI":"10.3389\/fmed.2021.790513","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:30:51Z","timestamp":1638873051000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Non-classical Vitamin D Actions for Renal Protection"],"prefix":"10.3389","volume":"8","author":[{"given":"Adriana S.","family":"Dusso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Bauerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bernal-Mizrachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1210\/jc.2009-1773","article-title":"Update in vitamin D","volume":"95","author":"Adams","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"g1903","DOI":"10.1136\/bmj.g1903","article-title":"Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies","volume":"348","author":"Chowdhury","year":"2014","journal-title":"BMJ."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2215\/CJN.01150308","article-title":"Vitamin D and kidney disease","volume":"3","author":"Al-Badr","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2011.09.002","article-title":"Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease","volume":"220","author":"Ellam","year":"2012","journal-title":"Atherosclerosis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1093\/ndt\/gfs160","article-title":"The emerging role of Klotho in clinical nephrology","volume":"27","author":"Hu","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1681\/ASN.2009030283","article-title":"25-hydroxyvitamin D levels, race, and the progression of kidney disease","volume":"20","author":"Melamed","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2215\/CJN.08680811","article-title":"Combined use of vitamin D status and FGF23 for risk stratification of renal outcome","volume":"7","author":"Nakano","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1210\/jcem-67-2-373","article-title":"Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin","volume":"67","author":"Webb","year":"1988","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1073\/pnas.0402490101","article-title":"Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase","volume":"101","author":"Cheng","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/ndt\/gfi186","article-title":"The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells","volume":"21","author":"Brown","year":"2006","journal-title":"Nephrol Dial Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/labinvest.2014.57","article-title":"Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma","volume":"94","author":"Bergada","year":"2014","journal-title":"Lab Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/ajcn\/87.6.1738","article-title":"25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions","volume":"87","author":"Heaney","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ki.2010.543","article-title":"Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease","volume":"79","author":"Dusso","year":"2011","journal-title":"Kidney Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00223-012-9619-0","article-title":"Molecular mechanisms of vitamin D action","volume":"92","author":"Haussler","year":"2013","journal-title":"Calcif Tissue Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/jn\/114.7.1313","article-title":"Defective photoproduction of cholecalciferol in normal and uremic humans","volume":"114","author":"Jacob","year":"1984","journal-title":"J Nutr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell."},{"key":"B21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1046\/j.1523-1755.2003.00114.x","article-title":"Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats","volume":"64","author":"Takemoto","year":"2003","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1046\/j.1365-2362.1998.00253.x","article-title":"Regulation of gp330\/megalin expression by vitamins A and D","volume":"28","author":"Liu","year":"1998","journal-title":"Eur J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1210\/jcem-59-6-1063","article-title":"Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3","volume":"59","author":"Halloran","year":"1984","journal-title":"J Clin Endocrinol Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ki.1988.190","article-title":"Extra-renal production of calcitriol in chronic renal failure","volume":"34","author":"Dusso","year":"1988","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ki.2012.222","article-title":"Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites","volume":"82","author":"Dai","year":"2012","journal-title":"Kidney Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ki.2012.193","article-title":"The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease","volume":"82","author":"Bosworth","year":"2012","journal-title":"Kidney Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8073","DOI":"10.1074\/jbc.M808090200","article-title":"Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3","volume":"284","author":"Saramaki","year":"2009","journal-title":"J Biol Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1128\/MCB.00353-06","article-title":"Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers","volume":"26","author":"Kim","year":"2006","journal-title":"Mol Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","article-title":"Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion","volume":"10","author":"Centeno","year":"2019","journal-title":"Nat Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jsbmb.2013.01.001","article-title":"The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites","volume":"136","author":"Giangreco","year":"2013","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e000407","DOI":"10.1161\/JAHA.113.000407","article-title":"Flank sequences of miR-145\/143 and their aberrant expression in vascular disease: mechanism and therapeutic application","volume":"2","author":"Liu","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbadis.2013.10.005","article-title":"Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease","volume":"1842","author":"Taibi","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e47807","DOI":"10.1371\/journal.pone.0047807","article-title":"Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223","volume":"7","author":"Rangrez","year":"2012","journal-title":"PLoS ONE."},{"key":"B35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ndt\/gfu318","article-title":"Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice","volume":"30","author":"Arcidiacono","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/10409231003628015","article-title":"ADAM-17: the enzyme that does it all","volume":"45","author":"Gooz","year":"2010","journal-title":"Crit Rev Biochem Mol Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nm1275","article-title":"Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach","volume":"11","author":"Lautrette","year":"2005","journal-title":"Nat Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ndt\/gfu311","article-title":"The induction of C\/EBPbeta contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease","volume":"30","author":"Arcidiacono","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11154-011-9199-8","article-title":"The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis","volume":"13","author":"Haussler","year":"2012","journal-title":"Rev Endocr Metab Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1046\/j.1523-1755.63.s85.3.x","article-title":"Vitamin D receptor: mechanisms for vitamin D resistance in renal failure","author":"Dusso","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/endo-128-4-1687","article-title":"On the mechanisms for the selective action of vitamin D analogs","volume":"128","author":"Dusso","year":"1991","journal-title":"Endocrinology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin d and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/eurjhf\/hfq112","article-title":"The vitamin D system: a crosstalk between the heart and kidney","volume":"12","author":"Cozzolino","year":"2010","journal-title":"Eur J Heart Fail."},{"key":"B44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1523-1755.2004.00402.x","article-title":"Regulation of gene expression by dietary Ca2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice","volume":"65","author":"Hoenderop","year":"2004","journal-title":"Kidney Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jsbmb.2009.11.011","article-title":"25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand","volume":"118","author":"Lou","year":"2010","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/JME-11-0008","article-title":"Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cells","volume":"47","author":"Munetsuna","year":"2011","journal-title":"J Mol Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3390\/nu11081918","article-title":"Native Hypovitaminosis D in CKD patients: from experimental evidence to clinical practice","volume":"11","author":"Alfieri","year":"2019","journal-title":"Nutrients."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","article-title":"Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study","volume":"30","author":"Fernandez-Martin","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B49","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1053\/ajkd.2001.20740","article-title":"Role of phosphorus in the pathogenesis of secondary hyperparathyroidism","volume":"37","author":"Slatopolsky","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"F454","DOI":"10.1152\/ajprenal.1996.270.3.F454","article-title":"Rat calcium-sensing receptor is regulated by vitamin D but not by calcium","volume":"270","author":"Brown","year":"1996","journal-title":"Am J Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1210\/jcem.81.4.8636374","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"B52","doi-asserted-by":"publisher","first-page":"30337","DOI":"10.1074\/jbc.M201804200","article-title":"Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D","volume":"277","author":"Canaff","year":"2002","journal-title":"J Biol Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands","volume":"21","author":"Canalejo","year":"","journal-title":"J Am Soc Nephrol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2215\/CJN.07131009","article-title":"A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease","volume":"5","author":"Moe","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/ndt\/gfx059","article-title":"High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: results of a 12-week double-blind, randomized, controlled study","volume":"33","author":"Westerberg","year":"2018","journal-title":"Nephrol Dial Transplant."},{"key":"B56","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ki.2008.549","article-title":"Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients","volume":"75","author":"Courbebaisse","year":"2009","journal-title":"Kidney Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1681\/ASN.2007111216","article-title":"Activator Protein 2{alpha} Mediates Parathyroid TGF-{alpha} Self-Induction in Secondary Hyperparathyroidism","volume":"19","author":"Arcidiacono","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1681\/ASN.2007040406","article-title":"EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease","volume":"19","author":"Arcidiacono","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"B60","first-page":"261","article-title":"A role for CCAAT\/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation","volume":"61","author":"Zahnow","year":"2001","journal-title":"Cancer Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1210\/jc.2013-3802","article-title":"A lifetime of hypercalcemia and hypercalciuria, finally explained","volume":"99","author":"Jacobs","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann","year":"2011","journal-title":"N Engl J Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1210\/endo.141.7.7579","article-title":"Deficient mineralization of intramembranous bone in vitamin D-24- hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D","volume":"141","author":"St-Arnaud","year":"2000","journal-title":"Endocrinology."},{"key":"B64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature."},{"key":"B65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1247\/csf.29.91","article-title":"Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice","volume":"29","author":"Li","year":"2004","journal-title":"Cell Struct Funct."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1681\/ASN.2013111209","article-title":"The kidney is the principal organ mediating klotho effects","volume":"25","author":"Lindberg","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bbrc.2011.09.117","article-title":"Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells","volume":"414","author":"Forster","year":"2011","journal-title":"Biochem Biophys Res Commun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-hydroxyvitamin D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1359\/jbmr.090516","article-title":"Klotho variants and chronic hemodialysis mortality","volume":"24","author":"Friedman","year":"2009","journal-title":"J Bone Miner Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MNH.0b013e3282ffd994","article-title":"The Klotho gene family and the endocrine fibroblast growth factors","volume":"17","author":"Kurosu","year":"2008","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B71","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.febslet.2004.03.090","article-title":"Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane","volume":"565","author":"Imura","year":"2004","journal-title":"FEBS Lett."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","article-title":"Suppression of aging in mice by the hormone Klotho","volume":"309","author":"Kurosu","year":"2005","journal-title":"Science."},{"key":"B74","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.semnephrol.2012.12.013","article-title":"Renal and extrarenal actions of Klotho","volume":"33","author":"Hu","year":"2013","journal-title":"Semin Nephrol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0095","article-title":"The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis","volume":"194","author":"Razzaque","year":"2007","journal-title":"J Endocrinol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1471-2369-14-221","article-title":"A low fractional excretion of Phosphate\/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients","volume":"14","author":"Craver","year":"2013","journal-title":"BMC Nephrol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/01.ASN.0000120389.09938.21","article-title":"Kidney-specific inactivation of the megalin gene impairs trafficking of renal inorganic sodium phosphate cotransporter (NaPi-IIa)","volume":"15","author":"Bachmann","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-018-0162-7","article-title":"Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice","volume":"558","author":"Fernandez","year":"2018","journal-title":"Nature."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/ki.2010.328","article-title":"Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective","volume":"78","author":"Hu","year":"2010","journal-title":"Kidney Int."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1681\/ASN.2015060613","article-title":"alphaKlotho mitigates progression of AKI to CKD through activation of autophagy","volume":"27","author":"Shi","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e983401","DOI":"10.4161\/19381980.2014.983401","article-title":"Vitamin D and inflammation","volume":"6","author":"Cannell","year":"2014","journal-title":"Dermatoendocrinology."},{"key":"B84","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/01.HYP.0000013734.33441.EA","article-title":"In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage","volume":"39","author":"Mitani","year":"2002","journal-title":"Hypertension."},{"key":"B85","doi-asserted-by":"publisher","first-page":"iv6","DOI":"10.1093\/ndt\/gfs426","article-title":"Klotho, phosphate and inflammation\/ageing in chronic kidney disease","volume":"4","author":"Izquierdo","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1681\/ASN.2014101030","article-title":"Renal production, uptake, and handling of circulating alphaKlotho","volume":"27","author":"Hu","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest."},{"key":"B88","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S2213-8587(14)70113-5","article-title":"Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study","volume":"2","author":"Vimaleswaran","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e0180512","DOI":"10.1371\/journal.pone.0180512","article-title":"Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data","volume":"12","author":"Rejnmark","year":"2017","journal-title":"PLoS ONE."},{"key":"B90","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.ki.5002572","article-title":"Renoprotective role of the vitamin D receptor in diabetic nephropathy","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int."},{"key":"B91","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10741-011-9232-8","article-title":"Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes","volume":"17","author":"Ronco","year":"2012","journal-title":"Heart Fail Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"F781","DOI":"10.1152\/ajprenal.90610.2008","article-title":"ADAM17 upregulation in human renal disease: a role in modulating TGF-{alpha} availability?","volume":"297","author":"Melenhorst","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"33714","DOI":"10.1074\/jbc.M704041200","article-title":"Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme\/ADAM17 expression by synovial cells","volume":"282","author":"Charbonneau","year":"2007","journal-title":"J Biol Chem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an Angiotensin-converting enzyme inhibitor and a vitamin d analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B96","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.2162","article-title":"The emerging role of ACE2 in physiology and disease","volume":"212","author":"Hamming","year":"2007","journal-title":"J Pathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"101295","DOI":"10.1016\/j.redox.2019.101295","article-title":"Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system","volume":"26","author":"Cui","year":"2019","journal-title":"Redox Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/ndt\/gfv025","article-title":"Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease","volume":"30","author":"Anguiano","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B101","doi-asserted-by":"publisher","first-page":"F534","DOI":"10.1152\/ajprenal.00082.2015","article-title":"Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria","volume":"310","author":"Riera","year":"2016","journal-title":"Am J Physiol Renal Physiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"9493","DOI":"10.1073\/pnas.1207293109","article-title":"Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B104","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1038\/s41467-019-13659-4","article-title":"SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection","volume":"10","author":"Gassen","year":"2019","journal-title":"Nat Commun."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00109-008-0375-6","article-title":"Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE\/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study","volume":"86","author":"Morange","year":"2008","journal-title":"J Mol Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.4049\/jimmunol.179.5.2686","article-title":"Cutting edge: TNF-alpha-converting enzyme (TACE\/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock","volume":"179","author":"Horiuchi","year":"2007","journal-title":"J Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jsbmb.2010.03.064","article-title":"Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality","volume":"121","author":"Dusso","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"F746","DOI":"10.1152\/ajprenal.1995.268.4.F746","article-title":"Kinetics of monocyte 1 alpha-hydroxylase in renal failure","volume":"268","author":"Gallieni","year":"1995","journal-title":"Am J Physiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1161\/CIRCRESAHA.116.305012","article-title":"Vascular smooth muscle cell calcification is mediated by regulated exosome secretion","volume":"116","author":"Kapustin","year":"2015","journal-title":"Circ Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature."},{"key":"B111","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/CIRCRESAHA.109.197517","article-title":"MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation","volume":"105","author":"Cheng","year":"2009","journal-title":"Circ Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1593\/neo.121222","article-title":"MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients","volume":"15","author":"Doberstein","year":"2013","journal-title":"Neoplasia."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/01.ATV.0000181743.28028.57","article-title":"Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury","volume":"25","author":"De Ciuceis","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1084\/jem.2017177301022018c","article-title":"Correction: the immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J Exp Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/s41467-020-18538-x","article-title":"Macrophage secretion of miR-106b-5p causes renin-dependent hypertension","volume":"11","author":"Oh","year":"2020","journal-title":"Nat Commun."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.790513\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:30:54Z","timestamp":1638873054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.790513\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":115,"alternative-id":["10.3389\/fmed.2021.790513"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.790513","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"article-number":"790513"}}